Literature DB >> 27363630

Borrmann type IV gastric cancer should be classified as pT4b disease.

Jin-Yu Huang1, Zhen-Ning Wang1, Chun-Yang Lu1, Zhi-Feng Miao1, Zhi Zhu1, Yong-Xi Song1, Hui-Mian Xu2, Ying-Ying Xu3.   

Abstract

BACKGROUND: The impact of macroscopic pathologic features of primary tumor that could be obtained preoperatively on pT classification has not been reported so far. The aim of this study was to investigate the feasibility of incorporation of Borrmann type IV gastric cancer into the pT classification.
MATERIALS AND METHODS: Clinicopathologic and prognostic data of 1622 patients with advanced gastric cancer who underwent radical surgery were retrospectively studied.
RESULTS: Of 1622 patients, 135 (8.32%) patients were classified as having Borrmann type IV gastric cancer. We first confirmed that Borrmann type IV gastric cancer was one of the independent prognostic factors for patients with advanced gastric cancer who underwent radical surgery. Interestingly, we found that overall survival of patients with Borrmann type IV gastric cancer could be clearly distinguished by pN classification and pathological TNM stage but not by pT classification. Importantly, further analysis demonstrated that the prognosis of Borrmann type IV gastric cancers was homogeneous with that of pT4b cancers but poorer than pT2, pT3, pT4a cancers. Therefore, we proposed a novel pT classification in which pT4b disease was defined as cancers that were Borrmann type IV or those that had invaded adjacent structures. Two-step multivariate analysis demonstrated that the novel pT classification was more suitable for prognostic assessment than the original classification.
CONCLUSIONS: Classifying Borrmann type IV gastric cancer as pT4b disease improves pT classification prediction of prognosis in patients with advanced gastric cancer after radical surgery.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Borrmann type; Gastric cancer; Macroscopic types; Prognosis; TNM; pT

Mesh:

Year:  2016        PMID: 27363630     DOI: 10.1016/j.jss.2016.04.026

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  CD103+ T Cells May Be a Useful Biomarker in Borrmann Type 4 Gastric Cancer.

Authors:  Takuya Mori; Hiroaki Tanaka; Sota Deguchi; Yuichiro Miki; Mami Yoshii; Tatsuro Tamura; Takahiro Toyokawa; Shigeru Lee; Kazuya Muguruma; Masaichi Ohira
Journal:  Cancer Diagn Progn       Date:  2022-05-03

2.  Prognostic impact and implications of extracapsular lymph node spread in Borrmann type IV gastric cancer.

Authors:  Rui-Zeng Dong; Jian-Min Guo; Ze-Wei Zhang; Yi-Min Zhou; Ying Su
Journal:  Oncotarget       Date:  2017-06-07

3.  Retrospective evaluation of lymphatic and blood vessel invasion and Borrmann types in advanced proximal gastric cancer.

Authors:  Shan Gao; Guo-Hui Cao; Peng Ding; Yang-Yang Zhao; Peng Deng; Bin Hou; Kai Li; Xiao-Fang Liu
Journal:  World J Gastrointest Oncol       Date:  2019-08-15

Review 4.  The significance of a nineteenth century definition in the era of genomics: linitis plastica.

Authors:  Annamaria Agnes; Jeannelyn S Estrella; Brian Badgwell
Journal:  World J Surg Oncol       Date:  2017-07-05       Impact factor: 2.754

5.  Analysis and external validation of a nomogram to predict peritoneal dissemination in gastric cancer.

Authors:  Xijie Chen; Shi Chen; Xinyou Wang; Runcong Nie; Dongwen Chen; Jun Xiang; Yijia Lin; Yingbo Chen; Junsheng Peng
Journal:  Chin J Cancer Res       Date:  2020-04       Impact factor: 5.087

6.  Prognostic impact of Borrmann classification on advanced gastric cancer: a retrospective cohort from a single institution in western China.

Authors:  Xiao-Hai Song; Wei-Han Zhang; Xiao-Long Chen; Lin-Yong Zhao; Xin-Zu Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  World J Surg Oncol       Date:  2020-08-13       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.